Benha Medical Journal

ORIGINAL ARTICLE
Year
: 2018  |  Volume : 35  |  Issue : 1  |  Page : 104--110

Sublingual misoprostol before insertion of an intrauterine device


Mohamed A Mohammed1, Khaled S Seleem1, Ahmed M Sadek1, Ahmed I Zaky Nada2 
1 Department of Obstetrics and Gynecology, Faculty of Medicine, Benha University, Benha, Egypt
2 Department of Obstetrics and Gynecology, Ministry of Health, Benha, Egypt

Correspondence Address:
Ahmed I Zaky Nada
Shebeen Elkom, Menoufya, 13511
Egypt

Objective The aim of the work was to investigate whether sublingual misoprostol before intrauterine contraceptive device (IUCD) insertion facilitates the insertion and reduces the number of failed insertions, insertion-related complications, and pain during insertion. Background The intrauterine device (IUD) is a highly effective and safe contraceptive method. However, insertion through a narrow cervix may be technically difficult and painful. Misoprostol has been shown to be effective for cervical priming in nonpregnant women. Patients and methods Two hundred and sixty women were randomly allocated to receive 400 mg misoprostol sublingually or placebo 2 h before IUD insertion. Primary outcome measure was the proportion of failed insertions. Pain during insertion and difficulty in IUCD insertion were evaluated. Complications and side effects were recorded together with bleeding and expulsion of the loop after 6 weeks. Results Misoprostol significantly reduced the number of failed insertions from six failed insertion in the placebo group (4.6%) to only one (0.8%) case in the misoprostol group (P=0.023). Pain during insertion was significantly lower (P<0.001). Difficulty in insertion was significantly lower (P<0.001). As regards side effects, no significant differences were found between the two groups except for abdominal cramps and nausea. Cramps occurred in 22.3% of participants using misoprostol and in 5.4% of participants using placebo (P<0.001). Nausea occurred in 6.9% of participants using misoprostol and in 1.5% of participants using placebo (P=0.046). There were no significant differences as regards the rate of expulsion and the amount of vaginal bleeding. Conclusion 400 micrograms of sublingual misoprostol 2 h before IUCD insertion reduces the number of failed insertions and pain during insertion. A facilitating effect of misoprostol on IUD insertion was also found.


How to cite this article:
Mohammed MA, Seleem KS, Sadek AM, Zaky Nada AI. Sublingual misoprostol before insertion of an intrauterine device.Benha Med J 2018;35:104-110


How to cite this URL:
Mohammed MA, Seleem KS, Sadek AM, Zaky Nada AI. Sublingual misoprostol before insertion of an intrauterine device. Benha Med J [serial online] 2018 [cited 2022 Jan 25 ];35:104-110
Available from: http://www.bmfj.eg.net/article.asp?issn=1110-208X;year=2018;volume=35;issue=1;spage=104;epage=110;aulast=Mohammed;type=0